Recap: Milestone Pharmaceuticals Q3 Earnings

Milestone Pharmaceuticals MIST reported its Q3 earnings results on Monday, November 13, 2023 at 06:57 AM.

Here's what investors need to know about the announcement.

Earnings

Milestone Pharmaceuticals beat estimated earnings by 7.89%, reporting an EPS of $-0.35 versus an estimate of $-0.38.

Revenue was down $1.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 3.94% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.